Fuelled by innovation, the outlook for the biotech sector remains positive and should be viewed separately from the macro environment, says Peter Hughes.
Financial crises loom in emerging markets
Issues around debt sustainability
Unprecedented hike of 0.75%
Should look at real-world impact